BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27416670)

  • 21. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.
    Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant Leydig-cell tumour of testis.
    Cervenakov I; Lepies P; Mardiak J; Ondrus B; Durcany V
    Int Urol Nephrol; 1984; 16(3):227-32. PubMed ID: 6480283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?
    Brown J; Sood AK; Deavers MT; Milojevic L; Gershenson DM
    Gynecol Oncol; 2009 Apr; 113(1):86-90. PubMed ID: 19162310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
    Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
    Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
    Cheng H; Peng J; Yang Z; Zhang G
    Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Leydig sex-cord tumors of the testis. The place of immunohistochemistry in diagnosis and prognosis. A study of twenty cases.
    Compérat E; Tissier F; Boyé K; De Pinieux G; Vieillefond A
    Virchows Arch; 2004 Jun; 444(6):567-71. PubMed ID: 15088145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bilateral Leydig cell tumor of the test: a case report].
    Slama A; Elleuch A; Yacoubi MT; Ben Sorba N; Mosbah AT
    Ann Urol (Paris); 2003 Aug; 37(4):213-6. PubMed ID: 12951717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leydig cell tumor: a report of two cases with unusual presentation.
    Sengupta S; Chatterjee U; Sarkar K; Chatterjee S; Kundu A
    Indian J Pathol Microbiol; 2010; 53(4):796-8. PubMed ID: 21045421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leydig cell tumor: a case report and review of the literature.
    Rao SR; Mistry RC; Parikh DM
    Tumori; 2002; 88(1):75-6. PubMed ID: 12004857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells.
    Ulbright TM; Srigley JR; Hatzianastassiou DK; Young RH
    Am J Surg Pathol; 2002 Nov; 26(11):1424-33. PubMed ID: 12409718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from 52 patients with leydig cell tumor of the testis: the GUONE (North-Eastern Uro-Oncological Group, Italy) experience.
    Di Tonno F; Tavolini IM; Belmonte P; Bertoldin R; Cossaro E; Curti P; D'Incà G; Fandella A; Guaitoli P; Guazzieri S; Mazzariol C;
    Urol Int; 2009; 82(2):152-7. PubMed ID: 19322000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malignant Leydig cell tumor].
    Kettani S; Fondimare A; Guyetant S; Faye R; Bertrand G
    Arch Anat Cytol Pathol; 1994; 42(6):317-20. PubMed ID: 7748005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testicular (gonadal stromal) fibroma: case report and review of the literature.
    Deveci MS; Deveci G; Ongürü O; Kilciler M; Celasun B
    Pathol Int; 2002 Apr; 52(4):326-30. PubMed ID: 12031091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unclassified sex cord/gonadal stromal testis tumor with predominance of spindle cells.
    Tarjàn M; Sarkissov G; Tot T
    APMIS; 2006 Jun; 114(6):465-9. PubMed ID: 16856970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors.
    Iczkowski KA; Bostwick DG; Roche PC; Cheville JC
    Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testis sparing surgery for Leydig cell pathologies in children.
    Emre S; Ozcan R; Elicevik M; Emir H; Soylet Y; Buyukunal C
    J Pediatr Urol; 2017 Feb; 13(1):51.e1-51.e4. PubMed ID: 27773621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic and immunohistochemical characterization of a testicular mixed germ cell sex cord-stromal tumor and a leydig cell tumor in a dog.
    Owston MA; Ramos-Vara JA
    Vet Pathol; 2007 Nov; 44(6):936-43. PubMed ID: 18039910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
    Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
    J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.